state Massachusets virus vaccine Manufacturing state Massachusets

Moderna’s vaccine facility in Montreal suburb could be operational by end of 2024

Reading now: 875
globalnews.ca

Moderna says construction of its new mRNA vaccine factory in the Montreal area will begin later this year, with production expected to begin by the end of 2024.The vaccine manufacturer is announcing that it has agreed to purchase land in a biotechnology park in Laval, Que., a northern suburb of Montreal, to serve as the site of its biomanufacturing facility.The Massachusetts-based company says the site is ideal due to its proximity to a renowned research institute, the Institut national de la recherche scientifique.Moderna announced in April that it would build a factory in the Montreal area that would be able to produce 100 million doses of mRNA vaccines a year.

Montreal chosen as location for new Canadian Moderna vaccine-manufacturing plant The facility is expected to produce vaccines not only against COVID-19 but also targeting various respiratory viruses, including influenza and respiratory syncytial virus, or RSV.The company says the facility is expected to be operational by the end of 2024, “subject to planning and regulatory approvals.”“This location offers tremendous synergies to Moderna due to its proximity to a renowned research institute, in addition to fitting the requirements of the project and its importance to all Canadians and Quebecers,” the company said in a news release.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

Fox Business - Johnson & Johnson to end sale of talc-based baby powder globally in 2023 - fox29.com - Usa - state California - Canada - county Johnson
fox29.com
60%
906
Johnson & Johnson to end sale of talc-based baby powder globally in 2023
SAN ANSELMO, CALIFORNIA - NOVEMBER 12: In this photo illustration a bottle of Johnson & Johnson baby powder is displayed on a table on November 12, 2021 in San Anselmo, California. Johnson & Johnson announced plans to split its pharma Johnson & Johnson will no longer sell its talc-based baby powder globally in 2023, the company said on Thursday, more than two years after it stopped selling the product in the United States and Canada."As part of a worldwide portfolio assessment, we have made the commercial decision to transition to an all cornstarch-based baby powder portfolio," it said in a statement to Fox Business.OVER 2K FLIGHTS DELAYED, OVER 600 CANCELED ON THURSDAYIn 2020, Johnson & Johnson announced that it would stop selling its talc Baby Powder in the United States and Canada, saying demand had fallen due to "misleading" information regarding the product's safety.The company faces about 38,000 lawsuits from consumers and their survivors claiming its talc products caused cancer due to contamination with asbestos, a known carcinogen.INFLATION HITS 8.5% ANNUALLY IN JULY, MONTHLY RATE REMAINS UNCHANGEDJohnson & Johnson denies the allegations, saying decades of scientific testing and regulatory approvals have shown its talc to be safe and that the product "does not contain asbestos and does not cause cancer."CLICK HERE TO READ MORE ON FOX BUSINESSJohnson & Johnson spun off subsidiary LTL Management in October, assigned its talc claims to it and immediately placed it into bankruptcy, pausing the pending lawsuits.Reuters contributed to this report.
Masks will be optional at Temple University for most indoor, outdoor parts of campus - fox29.com
fox29.com
46%
940
Masks will be optional at Temple University for most indoor, outdoor parts of campus
PHILADELPHIA - Temple University says masks will be optional in all non-healthcare indoor and outdoor settings to start the Fall semester."When it comes to masking, we encourage all members of the Temple community to make the best decision for themselves, taking into consideration all factors, including COVID-19 transmission levels, the indoor setting and their own health, while respecting the decisions of others to protect themselves," the school said in a press release. Temple is still encouraging students and staff to have a mask handy and be willing to wear it to keep vulnerable members of the school community safe. Free surgical masks are available at the entrance of every building, according to the school, and a limited number of KN95s are available in Main Campus buildings. MORE LOCAL HEADLINES"We will continue to monitor the situation and may have to make adjustments to our masking and other policies later in the semester depending on conditions, but for now, let’s be respectful to each other and take care of ourselves," the school said. Meanwhile, the Temple Association of University Professionals (TAUP) shared a statement saying it "does not agree with the university's decision on masks." They claim the decision was made without "meaningful consultation" with faculty or staff. TAUP is requesting that Temple allow instructors the option to require masking in their classrooms and teaching spaces.In accordance with Philadelphia's vaccine mandate on institutions of higher education, Temple students and staff are still required to have at least the original COVID-19 series.
DMCA